blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2280973

EP2280973 - CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.10.2013
Database last updated on 08.01.2025
Most recent event   Tooltip24.01.2014Change - lapse in a contracting state
State(s) deleted from list of lapses: CY
published on 26.02.2014  [2014/09]
Applicant(s)For all designated states
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2011/06]
Inventor(s)01 / CHO, Aesop
1656 Notre Dame Drive
Mountain View CA 94040 / US
02 / KIM, Choung, U.
1750 Elizabeth Street
San Carlos CA 94070 / US
03 / PARRISH, Jay
760 Bair Island Rd., 100
Redwood City CA 94063 / US
04 / XU, Jie
812 Rigel Lane
Foster City CA 94404 / US
 [2011/06]
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2012/48]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Former [2011/06]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Application number, filing date09735162.122.04.2009
[2011/06]
WO2009US41432
Priority number, dateUS2008004726323.04.2008         Original published format: US 47263
US2008013944919.12.2008         Original published format: US 139449
[2011/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009132123
Date:29.10.2009
Language:EN
[2009/44]
Type: A1 Application with search report 
No.:EP2280973
Date:09.02.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 29.10.2009 takes the place of the publication of the European patent application.
[2011/06]
Type: B1 Patent specification 
No.:EP2280973
Date:28.11.2012
Language:EN
[2012/48]
Search report(s)International search report - published on:EP29.10.2009
ClassificationIPC:C07D487/04, A61K31/395, A61K31/41, A61K31/4188, C07H19/23, A61K31/7052, A61P31/12
[2011/06]
CPC:
C07H19/23 (EP,CN,KR,US); C07D487/04 (EP,CN,KR,US); A61K31/12 (KR);
A61K31/395 (KR); A61K31/41 (KR); A61K31/4188 (KR);
A61K31/70 (KR); A61K31/7052 (KR); A61P1/16 (EP);
A61P31/00 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P31/16 (EP); A61P31/20 (EP); A61P43/00 (EP);
C07F9/6561 (CN); C07F9/65744 (CN); C07H1/00 (CN);
C07H19/00 (KR); C07H5/04 (KR); C07H5/06 (KR);
Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/06]
TitleGerman:CARBANUKLEOSIDANALOGA ZUR ANTIVIRUSBEHANDLUNG[2011/06]
English:CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT[2011/06]
French:ANALOGUES DE CARBA-NUCLÉOSIDE POUR UN TRAITEMENT ANTIVIRAL[2011/06]
Entry into regional phase29.10.2010National basic fee paid 
29.10.2010Designation fee(s) paid 
29.10.2010Examination fee paid 
Examination procedure29.10.2010Examination requested  [2011/06]
31.01.2011Amendment by applicant (claims and/or description)
13.07.2011Communication of intention to grant the patent
02.01.2012Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
09.01.2012Fee for grant paid
09.01.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.07.2011
Opposition(s)29.08.2013No opposition filed within time limit [2013/45]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
09.01.2012Request for further processing filed
09.01.2012Full payment received (date of receipt of payment)
Request granted
01.02.2012Decision despatched
Fees paidRenewal fee
25.04.2011Renewal fee patent year 03
25.04.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2014/09]
Former [2013/52]CY28.11.2012
Cited inInternational search[A]WO0056734  (AVENTIS CROPSCIENCE GMBH [DE]);
 [Y]WO02057287  (MERCK & CO INC [US], et al);
 [Y]WO2008005542  (GILEAD SCIENCES INC [US], et al);
 [PY]WO2008089105  (BIOCRYST PHARM INC [US], et al);
 [PY]WO2008141079  (BIOCRYST PHARM INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.